Mondobiotech.com Site Map
Company
Overview
Mission and values
Founder's Vision
Research vision
Rare diseases
Products
Partnership
Milestones
Fast Fact
Contact us
back to top
Products
Products
back to top
-
73 In Development
Target Not Disclosed -
Das Kloster 0141-01
Acute Respiratory Distress Syndrome (ARDS/ALI) -
DasKloster 0014-01
Hepatitis B Virus induced Hepatocellular Carcinoma -
DasKloster 0080-01
Lymphangioleiomyomatosis (LAM) -
DasKloster 0112-01
Sarcoidosis -
DasKloster 0210-01
Chronic Beryllium Disease (CBD) -
DasKloster 0249-01
Drug Resistant Tuberculosis -
DasKloster 1000-01
Pulmonary Arterial Hypertension (PAH) -
DasKloster 1000–04
Acute Respiratory Distress Syndrome (ARDS/ALI) -
DasKloster 1001-01
Idiopathic Pulmonary Fibrosis (IPF)
Media
back to top
Investor
Overview
Investors News and Events Hot to invest Key information Webcast & Presentation Financial Gallery FAQ
Investors News and Events Hot to invest Key information Webcast & Presentation Financial Gallery FAQ
Financial Information
Coporate Governance Board of Directors Board Committes Management Code of conduct Articles of Association Bylaws
back to top
Coporate Governance Board of Directors Board Committes Management Code of conduct Articles of Association Bylaws
Download
- Mondobiotech
- Fast fact
- Overview
- Milestones
- Board of Directors
- Management
- Location
- Products
- Product Overview
- Types of products
- Pipeline
- Rare Diseases
- About Rare Diseases
- Patient and Families
- Rare Diseases List
- Media Archive
- Investor
- Financial Information
- Key Information
- Corporate Governance
- Appointments
- Partnership
- Pipeline
- Science
- Pipeline
- Product Overview
- Research Vision
Copyright 2010 mondoBIOTECH holding AG, all rights reserved.
Terms and Conditions |
Privacy Policy |
Sitemap |
Contact Us |
Website Feedback |
FAQ |
RSS